CRO Timeline 1981-2012

Why constant communication and transparency are paramount to successful partnerships between pharmaceutical companies and CROs

Improving the site-sponsor relationship can get trials off on the right foot and on a path for success.

With variation in costs between different stakeholders in clinical trials, there is often disagreement on fair market value.

Authors highlighted outsourcing and the impact of the COVID-19 pandemic in these CRO/sponsor articles from 2023.

Can full-service outsourcing to CROs by large biopharma companies sustainably prosecute a clinical development portfolio?

A shared partnership culture is critical in navigating today’s complex terrain.